Signals, Powered By EquityPandit
Piramal Enterprise has said that it is aiming to expand presence of its pharma vertical in the global markets such as the US, Europe and Japan.
Piramal Enterprise has said in its annual report for 2016-17 that “Piramal will continue to add more generic hospital products both organically and inorganically to leverage its strong sales and distribution network, integrating acquired products and generating synergies.”
It further said that the company would “further expand presence in strong markets, including the US, Europe and Japan.”
